Overview of Emerging Contaminants and Associated Human Health Effects
Open accessThe DOI matches its Crossref record; 112 of the 113 references it cites were found in a registry or an index; 11 of the 104 sources its claims cite were checked for support.
Abstract
In recent decades, because of significant progress in the analysis and detection of trace pollutants, emerging contaminants have been discovered and quantified in living beings and diverse environmental substances; however, the adverse effects of environmental exposure on the general population are largely unknown. This review summarizes the conclusions of the comprehensive epidemic literature and representative case reports relevant to emerging contaminants and the human body to address concerns about potential harmful health effects in the general population. The most prevalent emerging contaminants include perfluorinated compounds, water disinfection byproducts, gasoline additives, manufactured nanomaterials, human and veterinary pharmaceuticals, and UV-filters. Rare but statistically meaningful connections have been reported for a number of contaminants and cancer and reproductive risks. Because of contradictions in the outcomes of some investigations and the limited number of articles, no significant conclusions regarding the relationship between adverse effects on humans and extents of exposure can be drawn at this time. Here, we report that the current evidence is not conclusive and comprehensive and suggest prospective cohort studies in the future to evaluate the associations between human health outcomes and emerging environmental contaminants.
Overview
CoChat Summary
TL;DR
This narrative review surveys emerging contaminants—perfluorinated compounds, disinfection byproducts, gasoline additives, manufactured nanomaterials, human and veterinary pharmaceuticals, and UV-filters—and their possible human health effects. It concludes that current evidence is not conclusive or comprehensive, with only rare but statistically meaningful associations reported for some contaminants and cancer or reproductive risks.
Key findings
- Across contaminant classes, the review reports suspected mutagenicity, teratogenicity, and carcinogenicity, but states there is no sufficient large-scale evidence proving causal associations with adverse human effects. The most prevalent emerging contaminants listed are perfluorinated compounds, water disinfection byproducts, gasoline additives, manufactured nanomaterials, human and veterinary pharmaceuticals, and UV-filters.
- For PFCs, Eriksen et al. studied 57,053 Danish participants and identified 67 liver, 128 pancreatic, 322 bladder, and 713 prostate cancer patients; results did not imply an association except for prostate cancer in Denmark. Hardell et al. found higher hereditary prostate cancer risk among 201 prostate cancer cases versus 186 controls after adjustment. Fei et al. reported adjusted fecundity odds ratios for highest versus lowest PFOS quartiles of 0.70, 0.67, and 0.74, and for PFOA of 0.72, 0.73, and 0.60 among 1,240 women. Frisbee et al. reported mean serum PFOA and PFOS of 22.7 ng/mL and 69.2 ng/mL among 12,476 children/adolescents in the C8 Health Program, with PFOA associated with increased total lipid and LDL-C and PFOS with increased total lipid, LDL-C, and HDL-C.
- For disinfection byproducts, Villanueva et al. enrolled 1,219 subjects and 1,271 matched participants; long-term THM exposure was associated with bladder cancer OR 2.10 (95% CI 1.09–4.02) for mean household THM >49 vs ≤8 μg/L, ingestion ≥35 μg/day OR 1.35 (95% CI 0.92–1.99), shower/bath duration OR 1.83 (95% CI 1.17–2.87), and swimming OR 1.57 (95% CI 1.18–2.09). Chang et al. reported adjusted bladder cancer mortality ORs of 1.8 (95% CI 1.18–2.74) and 2.11 (95% CI 1.43–3.11) for highest and intermediate TTHM groups. King et al. reported colon cancer OR 1.63 (95% CI 1.07–2.48) and rectal cancer OR 0.91 (95% CI 0.55–1.51) for ≥75 μg/L. Righi et al. found higher risks of renal defects (OR 3.30; 95% CI 1.35–8.09), abdominal wall defects (OR 6.88; 95% CI 1.67–28.33), and cleft palate (OR 4.1; 95% CI 0.98–16.8) at maternal chlorite exposure of 700 μg/L, and obstructive urinary defects (OR 2.88; 95% CI 1.09–7.63), cleft palate (OR 9.60; 95% CI 1.04–88.9), and spina bifida (OR 4.94; 95% CI 1.10–22) at chlorate exposure of 200 μg/L.
- Other findings include MTBE-exposed participants in Vojdani et al. showing abnormal apoptotic lymphocytes at 26.4 ± 1.8% versus 12 ± 1.3% in unexposed groups; Hakkola and Saarinen reporting higher fatigue and 20% nausea/headaches among 101 tanker drivers versus 100 milk delivery drivers; no statistically significant TiO2–lung cancer results and no significant evidence for SiO2 carcinogenicity in a meta-analysis of 28 cohorts and 15 case-controls; EE2 at 3 ng/L inducing male gonad developmental arrest in zebrafish; and BP-3 detected in 96% of American urine specimens and 85% of Swiss breast milk specimens.
Methods
- Narrative review synthesizing “comprehensive epidemic literature and representative case reports” relevant to emerging contaminants and human health; no primary data are collected.
- The review covers PFCs, disinfection byproducts, gasoline additives, manufactured nanomaterials, human and veterinary pharmaceuticals, and UV-filters, with qualitative summaries of selected studies.
- No systematic search strategy, inclusion criteria, or quantitative meta-analysis is reported in the text.
Limitations
- Stated: the current evidence is not conclusive or comprehensive; contradictions in outcomes and the limited number of articles prevent significant conclusions about adverse human effects and exposure levels; the authors recommend prospective cohort studies.
- Stated/evident: many included studies have design limits, including single PFC plasma measurement, cross-sectional confounding, single-hospital case-control data, small samples with deficient statistical power, and exposure-assessment limitations; animal and in vitro findings may not represent real human exposure.
- Evident: as a narrative review, the paper does not report a systematic search or risk-of-bias assessment, so selection and synthesis may be incomplete.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
9 Valid · 5 Not valid · 59 Not checked · 23 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Only studies made by Eriksen et al. and Hardell et al. showed statistical significant association between PFC concentration and prostate cancer [17, 20].”
§ Overview of Emerging Contaminants and Associated Human Health Effects > 2. Perfluorinated Compounds > 2.1. PFCs and Cancer
What the sources say
- Disputedcites [17] Eriksen K. T. Sørensen M. McLaughlin J. K. Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general danish population Journal of the National Cancer Institute 2009 101 8 605 609 10.1093/jnci/djp041 2-s2.0-64749093885 19351918 sourceExperimental — accuracy not yet measured
Our copy of Eriksen et al. (2009) reports no statistically significant association with prostate cancer: every prostate IRR in Table 2 (From the Editors) crosses the null (PFOS Q4 vs Q1, IRR = 1.38, 95% CI = 0.99 to 1.93; trend IRR = 1.05, 95% CI = 0.97 to 1.14), and the Abstract, Contribution and Implications sections state outright that plasma PFOA/PFOS concentrations 'appear not to be associated with risk of prostate, bladder, pancreatic, or liver cancer.' The Results (BRIEF COMMUNICATION) add that 'no linear trend in risk ... was observed for any cancers examined' and that the quartile analyses 'indicated no differences in incidence rate ratios,' attributing the modest prostate elevation to chance or a threshold. Thus the citing sentence's attribution of a statistically significant prostate-cancer association to this study is contrary to what the paper itself concludes; the comparative 'only studies by Eriksen et al. and Hardell et al.' framing is not something this paper addresses. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
- Not checked yetcites [20] Hardell E. Kärrman A. van Bavel B. Bao J. Carlberg M. Hardell L. Case-control study on perfluorinated alkyl acids (PFAAs) and the risk of prostate cancer Environment International 2014 63 35 39 10.1016/j.envint.2013.10.005 2-s2.0-84887579728 24246240 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Every source the paper cites for this claim was checked and supports it.
In the paper
“Employing fully adjusted logistic models, the results indicated that higher PFOS and PFOA serum levels were associated with current thyroid disease among a general adult population in the US.”
§ Overview of Emerging Contaminants and Associated Human Health Effects > 2. Perfluorinated Compounds > 2.2. PFCs and Other Health Effects
What the sources say
- Supportedcites [25] Melzer D. Rice N. Depledge M. H. Henley W. E. Galloway T. S. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey Environmental Health Perspectives 2010 118 5 686 692 10.1289/ehp.0901584 2-s2.0-77951707570 20089479 PMC2866686 source
The Conclusions (p. 1) state plainly that 'Higher PFOA and PFOS concentrations are associated with thyroid disease (and being on thyroid-related medication) in the NHANES U.S. general adult population representative study samples,' matching the claim's direction and population. The Abstract Results (p. 1) supply the 'fully adjusted logistic models' framing, reporting elevated odds of current treated thyroid disease in the top PFOA quartile in women (OR = 2.24; 95% CI, 1.38–3.65) and in the top PFOS quartile in men (OR = 2.68; 95% CI, 1.03–6.98). The Discussion (p. 6) adds that adjustment made only relatively minor differences to the key estimates, supporting robustness of the attributed association. (LLM, conf=0.88)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The three studies proposed that higher PFC serum levels might change thyroid hormone levels [26–28]; however, the results of these studies were contradictory in some aspects, such as serum PFC-related increases in T4 and fT4 and decreases in T3 and hypothyroidism.”
§ Overview of Emerging Contaminants and Associated Human Health Effects > 2. Perfluorinated Compounds > 2.2. PFCs and Other Health Effects
What the sources say
- Not checked yetcites [26] Knox S. S. Jackson T. Frisbee S. J. Javins B. Ducatman A. M. Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project The Journal of Toxicological Sciences 2011 36 4 403 410 10.2131/jts.36.403 2-s2.0-79961151348 21804304 source
- Partly supportedcites [27] Shrestha S. Bloom M. S. Yucel R. Perfluoroalkyl substances and thyroid function in older adults Environment International 2015 75 206 214 10.1016/j.envint.2014.11.018 2-s2.0-84918807079 25483837 PMC4272864 sourceExperimental — accuracy not yet measured
Our copy supports the core attribution: serum PFOS was positively associated with fT4 (4%) and T4 (9%) in older adults (Results, Table 4 passage) and the Conclusions state 'higher serum PFAS levels were associated with increments in fT4 and T4'; the Introduction also frames the literature as inconsistent ('both increases and decreases in serum thyroid hormones have been demonstrated… Inconsistent findings across studies'). However, the 'decreases in T3' element is not this study's finding — it reported no main effect on T3, only antagonistic PFOS×ΣPCB joint effects indicating marginal decreases, and it credits negative PFOS–T3 associations to Dallaire et al. 2009 (Discussion). Likewise 'hypothyroidism' is not this paper's result: its participants were free of clinically-diagnosed thyroid disease, and the hypothyroidism association is credited to Winquist and Steenland (2014) in the Discussion. (LLM, conf=0.80)
- Not checked yetcites [28] Webster G. M. Venners S. A. Mattman A. Martin J. W. Associations between Perfluoroalkyl acids (PFASs) and maternal thyroid hormones in early pregnancy: a population-based cohort study Environmental Research 2014 133 338 347 10.1016/j.envres.2014.06.012 2-s2.0-84904263809 25019470 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Frederiksen et al. investigated BP-3, a UV-filter, and found that it could be detected in 96% of American urine specimens and 85% of Swiss breast milk specimens analyzed [104]; however, UV-filter potential hazards on humans are difficult to assess using exposure data alone.”
§ Overview of Emerging Contaminants and Associated Human Health Effects > 7. Sunscreens/Ultraviolet Filters
What the sources say
- Partly supportedcites [104] Frederiksen H. Jensen T. K. Jørgensen N. Human urinary excretion of non-persistent environmental chemicals: an overview of Danish data collected between 2006 and 2012 Reproduction 2014 147 4 555 565 10.1530/rep-13-0522 2-s2.0-84896362520 24395915 sourceExperimental — accuracy not yet measured
The Urinary phenol excretion section reports detecting BP-3 in urine from Danish participants, and the discussion compares Danish BP-3 levels with American levels. Neither passage reports detection in 96% of American urine specimens or 85% of Swiss breast milk specimens; the paper does not present those as its findings. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Detected bacterial populations from gut of animals given antibiotics were about five times to be resistant to common antibiotic resistant microbial strains [99].”
§ Overview of Emerging Contaminants and Associated Human Health Effects > 6. Human and Veterinary Pharmaceuticals > 6.1. Veterinary Antibiotics (VAs)
What the sources say
- Partly supportedcites [99] McDonald L. C. Kuehnert M. J. Tenover F. C. Jarvis W. R. Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications Emerging Infectious Diseases 1997 3 3 311 317 10.3201/eid0303.970307 2-s2.0-0031178966 9284375 PMC2627647 sourceExperimental — accuracy not yet measured
In the discussion of possible community transmission (p. 313), the paper says antimicrobial resistance in enterococci was more prevalent in farm animals exposed to antimicrobial drugs. It does not give an approximately fivefold comparison or extend that finding to gut bacteria generally. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
55 more claims
Create a free account to see all 96 claims and to verify the 93 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 16
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Face and hand creams, anti-aging creams, body wash and shower gel, toothpaste, and shaving cream were the main exposure to phthalates in men and women from PCP products.”
From The dark side of beauty: an in-depth analysis of the health hazards and toxicological impact of synthetic cosmetics and personal care products (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The results of this study showed that the proportion of phthalates, bisphenol A, and triclosan in urine samples was calculated to be approximately 88–100%.”
From The dark side of beauty: an in-depth analysis of the health hazards and toxicological impact of synthetic cosmetics and personal care products (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“and its percentage in urine samples was 29% (14).”
From The dark side of beauty: an in-depth analysis of the health hazards and toxicological impact of synthetic cosmetics and personal care products (2024) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Overview of Emerging Contaminants and Associated Human Health Effects > 2. Perfluorinated Compounds > 2.1. PFCs and Cancer
“These four reports were relatively high-quality studies with long follow-up periods; however, only one study utilized a prospective exposure measurement [17].”
§ Overview of Emerging Contaminants and Associated Human Health Effects > 2. Perfluorinated Compounds > 2.1. PFCs and Cancer
“Vassiliadou et al. conducted a cross-sectional study in 2010 to measure the serum PFOA and PFOS levels among 40 hospitalized cancer patients at the St. Savas Anticancer Hospital in Athens [18].”
Citations
Cites
Sarmah, A. K., Meyer, M. T., & Boxall, A. B. A. (2006) · Chemosphere · doi:10.1016/j.chemosphere.2006.03.026 · Cited by 3,326 · cited 4×
“VAs are mainly divided into several pharmacological types: antimicrobial, anthelmintic, steroidal and nonsteroidal, antiinflammatory, antiparasitic, astringent, estrus synchronization, nutritional supplement, and growth promoter [92].”
BackgroundInfluentialRICHARDSON, S., PLEWA, M., WAGNER, E., SCHOENY, R., & DEMARINI, D. (2007) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.09.001 · Cited by 3,317 · cited 4×
“More than six hundred DBPs have been discovered, including iodinated trihalomethanes (THMs), aldehydes, ketones, halomethanes, hydroxy acids, carboxylic acids, alcohols, keto acids, esters, and even nitrosamines (NDMA) [9, 37].”
BackgroundInfluentialOccurrence, fate and effects of pharmaceutical substances in the environment- A review
Halling-Sørensen, B., Nors Nielsen, S., Lanzky, P. F., Ingerslev, F., Holten Lützhøft, H. C., & Jørgensen, S. E. (1998) · Chemosphere · doi:10.1016/s0045-6535(97)00354-8 · Cited by 3,285 · cited 3×
“Thus, there is increasing widespread concern about the potential influence of pharmaceutical residues in the environment [87].”
BackgroundEcotoxicology of human pharmaceuticals
Fent, K., Weston, A. A., & Caminada, D. (2006) · Aquatic Toxicology · doi:10.1016/j.aquatox.2005.09.009 · Cited by 3,223 · cited 5×
“Pharmaceuticals in the environment have ecotoxicological effects on some nontarget species that have the same active sites, such as organs, tissues, cells, and active molecules with target species [91].”
BackgroundInfluentialSources, fate and transport of perfluorocarboxylates
Prevedouros, K., Cousins, I. T., Buck, R. C., & Korzeniowski, S. H. (2006) · Environmental Science & Technology · doi:10.1021/es0512475 · Cited by 2,594 · cited 1×
“PFCs undergo wide transportation across all environmentalmedia, including direct sources, such as the production, use, and disposal of consumer products containing these compounds, and indirect sources, such as volatile and neutral PFC precursor degradation [9, 11].”
BackgroundWater Analysis: Emerging Contaminants and Current Issues
Richardson, S. D., & Ternes, T. A. (2014) · Analytical Chemistry · doi:10.1021/ac500508t · Cited by 2,144
Polyfluorinated Compounds: Past, Present, and Future
Lindstrom, A. B., Strynar, M. J., & Libelo, E. L. (2011) · Environmental Science & Technology · doi:10.1021/es2011622 · Cited by 1,628 · cited 1×
“Therefore, PFCs are regarded as persistent, bioaccumulative, and potentially hazardous to animals and humans [7, 9]; however, their transport pathways and global fate have not been adequately documented to date [9, 10].”
Backgroundvon Gunten, U. (2003) · Water Research · doi:10.1016/s0043-1354(02)00458-x · Cited by 1,345
Gavrilescu, M., Demnerová, K., Aamand, J., Agathos, S., & Fava, F. (2015) · New Biotechnology · doi:10.1016/j.nbt.2014.01.001 · Cited by 1,266 · cited 5×
“Our review demonstrates that these contaminants continuously produce emerging and urgent challenges to the soil, water, air, and ecosystems, particularly human health (Figure 1) [2].”
BackgroundInfluentialOccurrence, sources, and fate of pharmaceuticals in aquatic environment and soil
Li, W. C. (2014) · Environmental Pollution · doi:10.1016/j.envpol.2014.01.015 · Cited by 831
Research works printed but not linked: 2
- 10.1002/(sici)1099-1263(199705)17:1lt;s57::aid-jat411 · doi:10.1002/(sici)1099-1263(199705)17:1lt;s57::aid-jat411
- The Effects on Human Health of Subtherapeutic Use of Antimicrobials in Animal 1980 Washington, DC, USA National Academies Press 25032407
Cited by
Items 201–231 of 231
Challenges in Pharmaceutical and Industrial Wastewater Treatment
Varshney, V., Trivedi, N., Singh, B. K., Rajpoot, A. K., & Singh, V. K. (2025) · Advances in environmental engineering and green technologies book series · doi:10.4018/979-8-3693-8487-9.ch002 · Cited by 3
Ghangrekar, M. M., Kumar, S., & Chakraborty, I. (2022) · Water science and technology library · doi:10.1007/978-3-030-95542-7_5 · Cited by 1
Occurrence and Removal of Environmental Pollutants
Calvo‐Flores, F. G., Isac-Garcéa, J., & Dobado, J. A. (2017) · Wiley eBooks · doi:10.1002/9783527691203.ch2 · Cited by 1
Sandoval-Gío, J. J., Noreña‐Barroso, E., Escalante-Herrera, K. S., & Rodríguez‐Fuentes, G. (2021) · Research Square · doi:10.21203/rs.3.rs-211308/v1 · Cited by 2
Gutiérrez-León, D. G., & Serrano-Ramírez, T. (2019) · IEEE International Conference on Applied Science and Advanced Technology (iCASAT) · doi:10.1109/icasat48251.2019.9069516
“Chlorination is the most popular method used in systems to disinfect water [12]; nevertheless, it is not effective for some microorganisms and, during its implementation were generated powerful toxic byproducts for human being [13]- [14].”
MethodMussels and Marine Environmental Contaminants
Gosling, E. M. (2021) · Wiley eBooks · doi:10.1002/9781119293927.ch8
Lifecycle Assessment of Emerging Water Pollutants
Nisa, W.-U., Riaz, L., Saleem, A. R., Saleem, A. R., Qadeer, S., Malik, T. H., Bangash, N., Ara, T., & Rashid, A. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/97897815040739122010010
Engineered Biochar as Adsorbent for Removal of Emerging Contaminants from Aqueous and Soil Medium
Medyńska‐Juraszek, A., & Ćwieląg‐Piasecka, I. (2022) · Springer eBooks · doi:10.1007/978-981-19-2488-0_10 · Cited by 1
Handbook Ingeniería y Materiales Aplicados al Medio Ambiente TI
del Carmen, U. A., Figueroa‐Ramírez, S. J., Sierra-Grajeda, J. M. T., & del Carmen, U. A. (2022) · ECORFAN eBooks · doi:10.35429/h.2022.9.1.147
Degradación Fotocatalítica de Naproxeno con TiO2 Evonik-P25 y BaTiO3
del Carmen, U. A., González-Pereyra, D., Acosta, I., del Carmen, U. A., Zermeño, B., del Carmen, U. A., Edgar, M., & del Carmen, U. A. (2022) · ECORFAN eBooks · doi:10.35429/h.2022.9.64.79
Valera, M. S., Vela, N., Piuvezam, G., Mateo-Ramírez, F., Pimenta, I. D. S. F., & Martínez-Alcalá, I. M. (2023) · medRxiv · doi:10.1101/2023.02.15.23285961
Szerves mikroszennyezők kockázatbecslése a parti szűrésen alapuló ivóvízellátásban
Goda, Z. (2023) · Nemzeti Közszolgálati Egyetem · doi:10.17625/nke.2023.029
Subchronic Oral Exposure to Chlorpyrifos Decreases Butyrylcholinesterase in Wistar Rat
Sakinah, E. N., Supangat, S., Wisudanti, D. D., Abrori, C., Mustika, A., Wibsono, S., & Athoillah, N. (2024) · Althea Medical Journal · doi:10.15850/amj.v11n1.3133
Umeki, Y., Hala, D. N., & Petersen, L. H. (2024) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2024.110015
Emerging Contaminants and Ways to Reduce It
Priyadharsini, P., Soni, K., Nirmala, N., Kumar, S. S., Dawn, S. S., Bagaria, A., & Arun, J. (2024) · Environmental science and engineering · doi:10.1007/978-3-031-62898-6_12
Soil Pollutants of Emerging Concern and Their One Health Implications
Enerijiofi, K. E., Maduka, N., Ahuekwe, E. F., & Olaitan, M. E. (2024) · Springer eBooks · doi:10.1007/978-981-97-5276-8_5
Gupta, M. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-97-9922-0_10
Umeki, Y., Nolen, R. M., Hala, D. N., & Petersen, L. H. (2025) · Environmental Research · doi:10.1016/j.envres.2025.123004
Wani, A. A., Nishat, N., & Narasimharao, K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23923-6.00017-6
Removal of selected pharmaceutical pollutants from groundwater using colloidal activated carbon
Alghamdi, S., Tawabini, B., Basaleh, A. A., Benaafi, M., & Jillani, S. M. S. (2026) · Scientific Reports · doi:10.1038/s41598-026-36859-7
Tahir, M. F., Joy, R. M., D’Haen, J., Marchal, W., Pobedinskas, P., Haenen, K., Thoelen, R., & Ethirajan, A. (2026) · ACS Applied Polymer Materials · doi:10.1021/acsapm.5c04745 · Cited by 2
Castillo-Ferat, M. A., Salazar-Rábago, J. J., Garcia-Reyes, R. B., Botello-González, J., & Dávila-Guzmán, N. E. (2026) · Quimica Hoy · doi:10.29105/qh15.02-525
The Prospects, Difficulties, and Research Paths for Environmental Toxicology
Ilahi, M., Yogita, Chatterjee, S., & Chakraborty, N. (2026) · Springer eBooks · doi:10.1007/978-3-032-28619-2_11
Natural polymer hydrogels as extractive phases for organic compounds in sample preparation
Marinho, A., Vieira, G. A. L., Preidum, A. P., Miyata, I. C. R. V., Leite, D. C., & da Silva, B. J. G. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.119492
Yang, S., Zhou, X., Fu, N., Du, W., Hu, G., 钟读波, Lin, N., Pan, B., & Tao, S. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.6c06332
Jana, S., Matore, B. W., Murmu, A., Gawande, P., Shukla, D., Kumar, A., Singh, J., & Roy, P. P. (2026) · Discover Chemistry. · doi:10.1007/s44371-026-00993-y
“Common emerging contaminants encompass per-fluorinated compounds, by products of water disinfection, additives found in gasoline, artificially produced nanomaterials, pharmaceuticals used by humans and animals, and UV filters [2].”
Zarezadeh, E., Roudbari, A., Darvishmotevalli, M., & Noorisepehr, M. (2026) · Journal of Environmental Health Engineering · doi:10.66224/jehe.13.4.437
Soto-Verjel, J., Alvear-Ovallos, L., Cely-Avellaneda, E., Ramírez-Ríos, L. F., & Becerra-Moreno, D. (2026) · Ingeniería y Competitividad · doi:10.25100/iyc.v28i3.15651
Metadata
- Authors
- Lei, M., Zhang, L., Lei, J., Zong, L., Li, J., Wu, Z., & Wang, Z.
- Affiliations
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Corresponding author
- Wang, Zheng
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-12
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4680045
- OpenAlex
- W2184108524
- Semantic Scholar
- 5feca011857cadada2a64e242a59f8b6dc92bdd5
- Cited by
- 231
- References
- 113
- Citations by year
- 2026: 17 · 2025: 28 · 2024: 28 · 2023: 28 · 2022: 33 · 2021: 41 · 2020: 19 · 2019: 17 · 2018: 11 · 2017: 6 · 2016: 2 · 2015: 1
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Keywords
- emerging contaminants, human health effects, perfluorinated compounds, disinfection by-products, gasoline additives, engineered nanomaterials, pharmaceuticals, UV filters, cancer risk, reproductive risk, environmental exposure, trace contaminants
- MeSH terms
- Environmental Exposure, Environmental Monitoring, Environmental Pollutants, Fluorocarbons, Gasoline, Health, Humans, Population Groups, Nanostructures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.